Sol-Gel Technologies Ltd. SLGL
$ 0.47
9.18%
Annual report 2023
added 11-09-2024
Country |
Israel |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Alon Seri-Levy |
Employees in the company |
61 |
Shares |
27.1 M |
Market Cap[1] |
$ 12.7 M |
EBITDA (LTM) |
$ -28.2 M |
P/E (LTM) |
3.3 |
P/S (LTM) |
10.66 |
EPS (LTM) |
1.28 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.